Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells

Gut

Volumn 39, Issue 6, 1996, Pages 795-799

  Smoot, D T ^a,d   Resau, J H ^c   Earlington, M H ^a   Simpson, M ^a   Cover, T L ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

H. pylori; human gastric cell culture; vacuolating cytotoxin

Indexed keywords

CYTOTOXIN;

ARTICLE; CELL CULTURE; CYTOTOXICITY; ENDOSCOPY; EPITHELIUM CELL; EUKARYOTIC CELL; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; STOMACH EPITHELIUM;

EID: 0030473889     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.6.795     Document Type: Article

References (28)

1. Cover TL, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med 1996; 41: 85-117.
2. Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, et al. Helicobacter pylori and gastric carcinoma. Cancer 1990; 66: 2569-74.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
4. Hansson LE, Engstrand L, Nyren O, Evans DJ, Lingren A, Bergstrom R, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098-103.
5. Forbes GM, Glaser ME, Cullen DJE, Warren JR, Christiansen KJ, Marshall BJ, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258-60.
6. Labenz J, Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994; 89: 1785-8.
7. Leunk RD, Johnson PT, David BC, Draft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988; 26: 98-9.
8. Cover TL, Cao P, Murthy UK, Sipple MS, Blaser MJ. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 1992; 90: 913-8.
9. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995; 33: 1203-5.
10. Figura N, Guglielmetti P, Rossolinia A, Barberi A, Cusi G, Musmanno RA, et al. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 1989; 27: 225-6.
11. Atherton JC, Cao P, Peek RM Jr., Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7.
12. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267: 10570-5.
13. Cover TL, Tummuru MKR, Cao P, Thompson SA, Blaser MJ. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994; 269: 10566-73.
14. Schmitt W, Hass R. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein. Mol Microbiol 1994; 12: 307-19.
15. Phadnis SH, Iiver D, Janzon L, Normark S, Westblom TU. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 1994; 62: 1557-65.
16. Tricottet V, Bruneval P, Vire O, Camilleri PJ. Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol 1986; 10: 113-22.
17. Hessey SJ, Spencer J, Wyatt JI, Sabala G, Rathbone BJ, Axon ATR, et al. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 1990; 31: 134-8.
18. Cover TL, Cao P, Lind CD, Tham KT, Blaser MJ. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008-12.
19. Smoot DT, Resau JH, Naab T, Desbordes BC, Gilliam T, Bull-Henry K, et al. Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infect Immun 1993; 61: 350-5.
20. Cover TL, Puryear W, Perez-Perez GI, Blaser MJ. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Inject Immun 1991; 59: 1264-70.
21. Cover TL, Reddy LY, Blaser MJ. Effects of ATPase inhibitors on the response of Hela cells to Helicobacter pylori vacuolating toxin. Infect Immun 1993; 61: 1427-31.
22. Papini E, Bugnoli M, DeBernard M, Figura N, Rappuoli R, Montecucco C. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol Microbiol 1993; 7: 323.
23. Cover TL, Halter SA, Blaser MJ. Characterization of HeLa cell vacuoles induced by Helicobacter pylori broth culture supernatant. Hum Pathol 1992; 23: 1004-10.
24. Telford JL, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653-8.
25. Marchetti M, Arico B, Burroni D, Figura N, Rappuol R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995; 267: 1655-8.
26. Ghiara P, Marchetti M, Blaser MJ, Tummuru MKR, Cover TL, Segal ED, et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA and urease in a mouse model of disease. Infect Immun 1995; 63: 4154-60.
27. Zafriri D, Oron Y, Eisenstein BI, Ofek I. Growth advantage and enhanced toxicity of Escherichia coli adherent to tissue culture cells due to restricted diffusion of products secreted by the cells. J Clin Invest 1987; 79: 1210-6.
28. Ofek I, Zafriri D, Goldhar J, Eisenstein BI. Inability of toxin inhibitors to neutralize enhanced toxicity caused by bacteria adherent to tissue culture cells. Infect Immun 1990; 58: 3737-42.